Parkinson's disease is a neurodegenerative disorder characterized by a progressive loss of dopaminergic neurons of the substantia nigra pars compacta (SN). The etiology is largely unknown and there is no cure available. Although current pharmacotherapies are modestly successful in ameliorating motor deficits, late complications of the therapies limit their long-term utility. The paucity of adult CNS plasticity is a further limit to structural repair of the striatonigral system. However, there is recent evidence that some areas of the adult brain retain the ability of continued generation of new cells including neurons and that this process contributes to repair following neuronal injury. Our results show that continued cell generation occurs in the adult SN. In addition, we have evidence that the resident proliferating cells in the adult SN have the potential to give rise to neurons. We propose that continued cell generation in the adult SN can be exploited for future endogenous dopaminergic cell replacement therapies in Parkinson's disease. In this grant we will examine cell genesis in the adult SN under three conditions in vivo: cell genesis in the intact adult SN; cell genesis in the adult SN in behavioral paradigms that stimulate neurogenesis in other CNS regions; cell genesis in the SN in an experimental model for Parkinson's disease. These in vivo studies will be complemented by a set of experiments in which we will: investigate the characteristics of proliferating cells derived from the adult SN in vitro; define conditions which will enhance dopaminergic cell generation from these cells. The suggested experiments will provide the groundwork for possible future strategies in which we will try to manipulate cell genesis in the adult SN in order to restore the function of the injured adult SN.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
5R01AG008514-15
Application #
6509537
Study Section
Special Emphasis Panel (ZRG1-MDCN-6 (01))
Program Officer
Wise, Bradley C
Project Start
1989-07-01
Project End
2006-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
15
Fiscal Year
2002
Total Cost
$409,752
Indirect Cost
Name
Salk Institute for Biological Studies
Department
Type
DUNS #
005436803
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Singer, Oded; Marr, Robert A; Rockenstein, Edward et al. (2005) Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci 8:1343-9
Hashimoto, M; Rockenstein, E; Mante, M et al. (2004) An antiaggregation gene therapy strategy for Lewy body disease utilizing beta-synuclein lentivirus in a transgenic model. Gene Ther 11:1713-23
Lie, D Chichung; Song, Hongjun; Colamarino, Sophia A et al. (2004) Neurogenesis in the adult brain: new strategies for central nervous system diseases. Annu Rev Pharmacol Toxicol 44:399-421
Pizzo, Donald P; Paban, Veronique; Coufal, Nicole G et al. (2004) Long-term production of choline acetyltransferase in the CNS after transplantation of fibroblasts modified with a regulatable vector. Brain Res Mol Brain Res 126:1-13
Hashimoto, Makoto; Kawahara, Kohichi; Bar-On, Pazit et al. (2004) The Role of alpha-synuclein assembly and metabolism in the pathogenesis of Lewy body disease. J Mol Neurosci 24:343-52
Marr, Robert A; Rockenstein, Edward; Mukherjee, Atish et al. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 23:1992-6
Hashimoto, Makoto; Rockenstein, Edward; Crews, Leslie et al. (2003) Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer's and Parkinson's diseases. Neuromolecular Med 4:21-36
Dickinson-Anson, Heather; Winkler, Jurgen; Fisher, Lisa J et al. (2003) Acetylcholine-secreting cells improve age-induced memory deficits. Mol Ther 8:51-61
Horner, Philip J; Gage, Fred H (2002) Regeneration in the adult and aging brain. Arch Neurol 59:1717-20
Lie, D Chichung; Dziewczapolski, Gustavo; Willhoite, Andrew R et al. (2002) The adult substantia nigra contains progenitor cells with neurogenic potential. J Neurosci 22:6639-49

Showing the most recent 10 out of 40 publications